| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |